Wearables & Devices

Wearable robotics expert Myomo Announces MyoPro® 2+

Company Continues to Innovate with Digital Technologies

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced the availability of MyoPro 2+, an enhanced version of its popular MyoPro powered brace. Deliveries to patients will begin this month.

Building on the MyoPro 2, MyoPro 2+ offers lighter weight, easier donning, greater comfort, and improved grasp functionality. Software and firmware enhancements include more powerful and simplified configuration options for clinicians and users as well as customizable speed control for more natural arm movement.

“The user experience is at the core of all our innovations. With this enhancement, not only will our adult and adolescent patients engage with the MyoPro 2+ in ways that make it more functional for them, they will also see a dramatic improvement in the ability to tailor the device to their preferences, including two harness options and more than 30 color and pattern styles, enabled by the introduction of 3D printing of the orthotic components”, explained Shiven Ruparel, Director of Product Management.

Advancing Myomo’s custom fabrication process, MyoPro 2+ will now be fabricated in-house at the Company’s Boston headquarters. This state-of-the-art operation will streamline the customer journey from evaluation to product delivery. MyoPro 2+ ensures a better device fit while lowering production costs and improving delivery times and convenience for patients.

Paul R. Gudonis, Myomo CEO, said “Our goals for MyoPro 2+ were to improve the experience and functionality for our users while at the same time reducing costs and cycle times for Myomo. Our field trials indicate we have accomplished both. Myomo is growing rapidly, and these enhancements are expected to further support our ability to scale up and offer increased upper limb functionality to more and more people.”

For more such updates and perspectives around Digital Innovation, IoT, Data Infrastructure, AI & Cybersecurity, go to AI-Techpark.com.

Related posts

Healthtech Company Asensus Surgical Announces FDA Clearance

Business Wire

Vizient Releases the Latest Issue of Medical Device Tech Watch

Business Wire

Eastwall and AOG announced new partnership

PR Newswire